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Abstract Burkholderia glumae is a Gram-negative phyto-
pathogenic bacterium known as the causative agent of rice
panicle blight. Strain B. glumae PG1 is used for the production
of a biotechnologically relevant lipase, which is secreted into
the culture supernatant via a type II secretion pathway. We
have comparatively analyzed the genome sequences of
B. glumae PG1 wild type and a lipase overproducing strain
obtained by classical strain mutagenesis. Among a total num-
ber of 72 single nucleotide polymorphisms (SNPs) identified
in the genome of the production strain, two were localized in
front of the lipAB operon and were analyzed in detail. Both
mutations contribute to a 100-fold overproduction of extracel-
lular lipase in B. glumae PG1 by affecting transcription of the
lipAB operon and efficiency of lipase secretion. We analyzed
each of the two SNPs separately and observed a stronger in-
fluence of the promoter mutation than of the signal peptide
modification but also a cumulative effect of both mutations.
Furthermore, fusion of the mutated LipA signal peptide
resulted in a 2-fold increase in secretion of the heterologous
reporter alkaline phosphatase from Escherichia coli.
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Introduction
Burkholderia glumae (formerly known as Pseudomonas
glumae) belongs to the genus Burkholderia within the sub-
phylum of the β-proteobacteria (Yabuuchi et al. 1992).
B. glumae is a moderate rice pathogen (Ham et al. 2011),
which also affects several other plants (Jeong et al. 2003).
Until now, just a single case of B. glumae isolated from an
immunodeficient patient was reported (Weinberg et al. 2007).
All B. glumae strains studied so far infect rice panicles and
produce a phytotoxin called toxoflavin (Jung et al. 2011; Kim
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et al. 2004; Suzuki et al. 2004; Vial et al. 2007), whose pro-
duction is regulated by a LuxR-LuxI-type quorum sensing
(QS) system (Chun et al. 2009; Chung et al. 2011; Goo et al.
2010; Kang et al. 2008; Kim et al. 2012; Kim et al. 2007).
Biotechnological applications of Burkholderia species mainly
comprise their use as biofertilizers or bioremediation agents
(Chiarini et al. 2006; Paganin et al. 2011; Suarez-Moreno et al.
2012). Furthermore, the production of an extracellular lipase
(Boekema et al. 2007; Santambrogio et al. 2013) and of
rhamnolipid biosurfactants (Costa et al. 2011) were described,
but detailed studies regarding further biotechnological appli-
cations are missing.
Lipases represent the third largest group within the world-
wide enzyme market, which is estimated to increase with a
6.3 % rate per year to reach US$6.9 billion in 2017 (Casas-
Godoy et al. 2012; Freedonia 2014; Hasan et al. 2006). The
production of biotechnologically relevant lipases is a well-
known feature of bacteria belonging to the genera
Pseudomonas and Burkholderia. These and other microbial
lipases (triacylglycerol hydrolases, EC 3.1.1.3) belong to the
family of α/β hydrolases and catalyze the hydrolysis of tri-
glycerides to glycerol and fatty acids. They are the most fre-
quently used biocatalysts in organic chemistry (Jaeger et al.
1999; Sharma and Kanwar 2014) as they are readily available
at low production costs, do not require cofactors, and usually
show a broad substrate specificity and high enantioselectivity
as well as high stability in non-aqueous media such as ionic
liquids, supercritical fluids, and organic solvents. Under non-
aqueous reaction conditions, lipases can catalyze the synthesis
of various esters by esterification, interesterification, and
transesterification (Aravindan et al. 2007; Gandhi et al.
2000; Gupta et al. 2004; Jaeger et al. 1999; Jaeger and
Eggert 2002; Jaeger et al. 1994; Jaeger and Reetz 1998;
Krishna and Karanth 2002; Nagarajan 2012; Yahya et al.
1998). Additional fields of lipase application include the pro-
duction of food and feed ingredients as well as intermediates
for pharmaceuticals (Casas-Godoy et al. 2012; Jaeger and
Eggert 2002) and, more recently, also the production of bio-
diesel (Narwal and Gupta 2013; Santambrogio et al. 2013).
Research over the last decades focused on the development of
new methods to improve enzymes by directed evolution, ra-
tional design and computational methods (Bornscheuer et al.
2012; Drepper et al. 2006). However, efficient expression and
preferably also secretion of lipases are still problematic, and
many biotechnologically interesting lipases, e.g., those pro-
duced by Pseudozyma aphidis (formerly Candida antarctica)
or various Pseudomonas species, can be produced but not
efficiently secreted in Escherichia coli thus requiring optimi-
zation of homologous expression strains (Liu et al. 2006;
Omori et al. 2005). Efficient secretion of enzymes into the
culture medium is favored for most applications because it
facilitates down-stream processing and lowers costs.
P. aeruginosa is a well-studied Gram-negative bacterium for
which a wealth of molecular biological and biochemical
methods are available (Filloux and Ramos (Eds.) 2014), and
it also produces and secretes biotechnologically relevant com-
pounds including lipases and rhamnolipid biosurfactants
(Dusane et al. 2010; Rosenau and Jaeger 2000). However, as
an opportunistic human pathogen, P. aeruginosa will not be
used for the majority of industrial applications. The company
BASF SE discovered that a lipase similar to the one produced
by P. aeruginosa is secreted by B. glumae PG1 and can be
used to produce enantiopure alcohols and amines as interme-
diates in the synthesis of pharmaceuticals (Balkenhohl et al.
1997; Boekema et al. 2007). Classical mutagenesis methods
were applied to construct the lipase overproducing strain
B. glumae LU8093 derived from the PG1 wild type (R.
Braatz, R. Kurth, E. Menkerl-Conen, H. Rettenmaier, T.
Friedrich, and T. Subkowski, 1992, patent application
WO93/00924 A1 and (Boekema et al. 2007)). Further muta-
genesis resulted in strain B. glumae LU2023, which showed
improved activity of another biotechnological relevant en-
zyme, a butyneol I esterase (T. Friedrich, B. Hauer, C.
Nuebling, R. Stuermer, 2001, patent applicat ion
WO2002018560 A2).
The extracellular lipase LipA is encoded in an operon to-
gether with a second gene lipB (or lif) encoding a lipase-
specific foldase (Frenken et al. 1993a; Frenken et al. 1993b;
Frenken et al. 1992). The N-terminal signal peptide of LipA
mediates its transport through the inner membrane via the Sec
secretion system (Frenken et al. 1992). In the periplasm, the
steric chaperone LipB interacts with the lipase (Frenken et al.
1993b; Rosenau and Jaeger 2000) resulting in the conversion
of the enzymatically inactive so-called Bnear-native^ state into
an active conformation (El Khattabi et al. 2000; Pauwels et al.
2012). Secretion through the outer membrane is subsequently
achieved via the type II secretion system formed by the so-
called Bsecreton^ (or Bmain terminal branch^ of the general
secretory pathway) (Filloux 2004).
In this study, two mutations in the lipase overproducing
strain B. glumae LU8093, one inside and one in front of the
lipase operon lipAB, were studied in detail to unravel their
contribution to lipase overproduction. Furthermore, we dem-
onstrated that increased secretion by the modified LipA signal
peptide can be transferred to the secretion of the reporter en-
zyme PhoA.
Material and methods
Bacterial strains and growth conditions
E. coli strains DH5α (Grant et al. 1990) and S17-1 (Simon
et al. 1983) were cultivated in LB medium (Carl Roth,
Karlsruhe, Germany) at 37 °C. B. glumae LU8093
((Balkenhohl et al. 1997) and R. Braatz, R. Kurth, E.
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Menkerl-Conen, H. Rettenmaier, T. Friedrich, and T.
Subkowski, 1992, patent application WO 93/00924 A1),
B. glumae PG1 wild type ((Frenken et al. 1992), and its
lipAB deficient derivate B. glumae PG1ΔlipAB (Knorr
2010) were cultivated in LB medium at 30 °C. For anal-
ysis of lipase activities and transcript-level determination,
B. glumae strains were cultivated for 14 h at 150 rpm.
Standard cloning experiments were performed in E. coli
DH5α. Plasmids were stabilized by using appropriate
concentrations of chloramphenicol (50 μg/ml for E. coli
and 200 μg/ml for B. glumae). Expression of the lipAB
operon from plasmid pBBR-lipAB harboring its natural
promoter was defined as native expression level. The wild
type strain B. glumae PG1 is deposited as strain no. CBS
322.89 at the Centraalbureau voor Schimmelcultures,
P.O.Box 85167, NL-3508 AD Utrecht, The Netherlands,
and the closed genome sequence of B. glumae PG1 is
deposited at the DDBJ/EMBL/GenBank under the acces-
sion CP002580 (chromosome 1) and CP002581 (chromo-
some 2) (Voget et al. 2015).
Genome sequencing and SNP analysis of B. glumae
LU8093
Genomic DNA of B. glumae LU8093 was isolated with the
Masterpure DNA purification Kit (Epicentre, Madison, USA).
Genome sequencing was carried out with a hybrid approach
using the 454 GS-FLX system with Titanium chemistry
(Roche Life Science, Mannheim, Germany) and the Genome
Analyzer IIx (Illumina, San Diego, CA). Sequencing results in
437,363 and 3,998,786 reads, respectively. In order to identify
SNPs, sequence reads of LU8093 were mapped onto the
B. glumae PG1 reference genome (Voget et al. 2015) with
the GS Reference Mapper (Roche Life Science, Mannheim,
Germany). All candidate SNP positions were then manually
verified by PCR-amplifying corresponding genome re-
gions and re-sequencing these fragments. Manual editing
steps were performed using the GAP4 software package
v4.6 (Staden 1996).
Recombinant DNA techniques
Standard DNA techniques were performed as described
(Sambrook et al. 1989). PCR Extender System (5 Prime,
Hilden, Germany) was used for amplification of DNA frag-
ments. Other DNA-modifying enzymes were obtained from
Thermo Scientific (St. Leon-Rot, Germany) using the manu-
facturer’s instructions. Plasmid isolation from E. coli DH5α
was performed with innuPREP Plasmid Mini Kit (Analytic
Jena, Jena, Germany). Genomic DNA from B. glumae PG1
(wild type) and B. glumae LU8093 was isolated using
DNeasy® Blood & Tissue Kit (Qiagen, Hilden, Germany).
The lipAB wild type operon (GenBank accession number:
AJK49931.1 and AJK49932.1) and the lipAB operon that har-
bors the mutations in the promoter region and the region cod-
ing for the LipA signal peptide were amplified using the iso-
lated genomic DNAs from both strains as template and the
primer pair BPG1 lipAB up/dn^ (5′-ATA TAT ATC TAG AAT
TCA CCG GAT CGA TCG-3′/5′-ATA TAT AAG CTT ACC
CGT TCG AAG CAC T-3′). The PCR products include
249 bp upstream of the lipA startcodon with the predicted
promoter sequence. The resulting DNA fragments harboring
primer introduced restriction sites were hydrolyzed with XbaI
andHindIII, and the resulting 2444-bp fragments were ligated
into XbaI-HindIII-treated plasmid pBBR1-MCS (Kovach
et al. 1994). The resulting plasmids were named pBBR-
lipAB and pBBR-lipAB-3, respectively. Plasmid pBBR-
lipAB was used as template for overlap-extension PCRs
(Higuchi et al. 1988) to introduce single mutations. For the
mutation in the promoter region, the primer pair BOLE PCR
1/2^ (5′-CCT GTC TAC AAT CAG ACG GCC G-3′/5′-CGG
CCG TCT GAT TGT AGA CAG G-3′) was used whereas the
pair BOLE PCR 3/4^ (5′-GGA ACG CAT CAATCT GAC CAT
G-3′/5′-CAT GGT CAG ATT GAT GCG TTC C-3′) was used
for the mutation in the region coding for the signal peptide.
The primer pair BPG1 lipAB up/dn^ was used as flanking
primers, and the resulting 2463 bp amplicon was then treated
as described above. The resulting plasmids were named
pBBR-lipAB-1 (mutation in the promoter region) and
pBBR-lipAB-2 (mutation in the signal sequence).
Transformation and conjugation
E. coli strains were transformed with plasmid DNA by heat
shock transformation (Hanahan 1983). B. glumae strains were
transformed by biparental mating with E. coli S17-1 as fol-
lows: For conjugation, 1 ml overnight culture of B. glumae
was mixed with 2 ml of E. coli S17-1 in the exponential
growth phase (O.D.580nm = 0.6–0.8) containing the plasmid
of interest. After centrifugation (1 min, 21,000×g), the cell
pellet was washed with 0.5 ml LB medium, resuspended in
50 μl LB medium and dropped onto a membrane filter (M24,
Whatman) placed on an LB agar-plate. Cells were washed off
from the filter with LB medium after 6 h at 30 °C, and the cell
suspension was plated in appropriate dilutions on MME
(Vogel and Bonner 1956) agar plates containing antibiotics
and 0.5 % (w/v) glucose.
Western blot analysis
Proteins from cell-free supernatants were precipitated with
sodium deoxycholate and trichloroacetic acid (TCA) as de-
scribed (Peterson 1977). After washing with 1/2 volume
80 % (v/v) acetone, the pellet was suspended with 2× SDS-
sample puffer (50 mM Tris-HCl, 4 % (w/v) SDS, 10 % (v/v)
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glycerol, 10 % (v/v) 2-mercaptoethanol, 0.03 % (w/v)
bromophenol blue). Proteins were separated by SDS-PAGE
with a 12% polyacrylamide gel (Laemmli 1970).Western blot
analysis of LipA and LipB was performed using specific an-
tibodies (kindly provided by Jan Tommassen, University of
Utrecht, The Netherlands). A goat-anti-rabbit IgG (H +
L)-HRP conjugate (BioRad, Munich, Germany) was used
as secondary antibody. Specific antibody-protein interac-
tions were detected using the ECL Western Blotting
D e t e c t i o n s y s t e m ( Am e r s h a m P h a r m a c i a ,
Buckinghamshire, GB) and the luminescence detector
Stella (raytest, Straubenhardt, Germany).
Lipase assay
Lipase activity in whole cell extracts and supernatants was
measuredwith para-nitrophenyl palmitate (p-NPP) as the sub-
strate (Winkler and Stuckmann 1979) at 410 nm in microtiter
plates using a SpectraMax 250 photometer (Molecular
Devices, Ismaning/München, Germany). Relative lipase ac-
tivity was correlated to cell density (O.D.580nm) and calculated
as U/ml, with 1 U (unit) defined as the amount of lipase that
releases 1 mmol of para-nitrophenol per minute (molar ab-
sorption coefficient 15 μMol−1 × cm−1).
Transcript level determination
Two milliliters of culture were centrifuged (1 min, 21,000×g)
and washed once with TE buffer (100 mM Tris-HCl pH 7.5,
20 mM EDTA). The cell pellet was then treated with RNeasy
Mini Kit (Qiagen) according to the protocol for the isolation of
bacterial RNA. DNaseI digestion was performed both, Bon
column^ with RNase-free DNase Set (Qiagen) and after
RNA elution with DNaseI (RNase-free) from Ambion®
(Life Technologies, Darmstadt, Germany) according to the
manufacturer’s instructions. The reverse transcription of iso-
lated RNA into cDNAwas carried out with the High Capacity
cDNA Reverse Transcription Kit (Applied Biosystems™,
Foster City, USA) according to the instruction manual. For
subsequent real time qPCRs, 250 ng RNA were transcribed
per reaction. In a separate reaction, each sample was also
treated without reverse transcription to exclude DNA contam-
inations. The analysis of transcriptional levels of lipA and lipB
was performed with real time qPCR (35 cycles) using the
ΔΔCT-method (Livak and Schmittgen 2001; Schmittgen
and Livak 2008). Here, the cDNAwas used as template in a
real time 7900HT Fast Real-Time PCR System with Power
SYBR® Green PCR Maste r Mix (bo th Appl ied
Biosystems™), and specific primers for lipA (5′-CTA TCC
GGT GAT CCT CGT C-3′/5′-GAG AGA TTC GCG ACG
TAC AC-3′), lipB (5′-GTG GCA GAC GCG CTA TCA AG-
3′/5′-CGT GAA AGT CTG CTG CCT GAG-3′) and the con-
stitutively expressed gene rpoD (5′-GAT GAC GAC GCA
ACC CAG AG-3′/5′-GAA CGC TTC CTT CAG CAG CA-3′)
as a reference. Primers were designed using Primer3
(Untergasser et al. 2012). The amount of PCR product was
calculated as CT value by the Sequence Detection System
(Version 2.3, Applied Biosystems™). PCR efficiencies were
determined with the tool LinRegPCR (Ruijter et al. 2009).
The CT values obtained for lipA and lipB were then related
to those of the reference gene rpoD leading to theΔCT value
(ΔCT = CT(gene) − CT(rpoD)). By comparing the ΔCT
values of a certain strain to its reference strain, the resulting
ΔΔCT (ΔΔCT =ΔCT(strain) −ΔCT(reference strain)) val-
ue reflects the differences in the transcript amount of a
certain gene between these two strains. Calculations were
performed and statistically analyzed with REST© software
(Pfaffl et al. 2002). All observed transcript exchanges are
significantly different from the control sample (p < 0.05,
calculated with REST©).
Results
Comparison of B. glumae wild type and the lipase
production strain LU8093
The extracellular lipase LipA produced by B. glumae PG1 is
used by BASF SE for the production of enantiopure building
blocks (Liese et al. 2006). Therefore, the lipase production
strain B. glumae LU8093 was constructed from B. glumae
PG1 by repeated rounds of random mutagenesis and subse-
quent assays for increased extracellular lipase production R.
Braatz, R. Kurth, E. Menkerl-Conen, H. Rettenmaier, T.
Friedrich, and T. Subkowski, 1992, patent application WO
93/00924 A1). We compared the genome sequences of
B. glumae PG1 (Voget et al. 2015) and B. glumae LU8093
and identified in the production strain 72 SNPs of which 51
were located on chromosome 1, with 29 non-synonymous,
16 synonymous and six intergenic ones. From 21 SNPs
found on chromosome 2, 13 were non-synonymous, five
synonymous and three intergenic. Among the 72 SNPs
identified in the B. glumae LU8093 chromosomes, two
were localized within the lipase operon on chromosome
2; one in the putative promoter region and the second in
the region encoding the LipA signal peptide (Fig. 1).
We first determined lipase activity and protein amount in
cell extracts and culture supernatants obtained from B. glumae
PG1 wild type and the production strain LU8093 demonstrat-
ing that the production strain produced more lipase than the
wild type (Fig. 2a). Previous studies using fusions of the lipase
promoter with GFP indicated an increased transcription
rate of lipA in the production strain B. glumae LU8093
(Boekema et al. 2007). Thus, we quantified the transcription
levels of lipA by qPCR and determined a 100-fold increase in
the production strain (Fig. 2b).
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Two mutations localized within the lipase operon lipAB
increase lipase production and secretion
The mutations identified in front of the lipAB operon were
analyzed both separately and in combination by expression
of the respective genes in a lipAB-deficient B. glumae PG1
strain (PG1ΔlipAB) to avoid basal expression of genome-
encoded lipAB. To ensure that extracellular lipase activities
were not caused by cell lysis, we determined cytoplasmic β-
lactamase activities in cell-free culture supernatants. These
activities were always less than 10 % of the overall activities
for all strains tested (Fig. S1) indicating that the observed
effects of the mutations on extracellular lipase levels were
not caused by significant cell lysis. As shown in Fig. 3a, the
mutation in the promoter region of lipAB (lipAB-1) resulted in
a 38-fold increased lipase activity in the supernatant (~2.68
compared to ~0.07 U/ml) and 42-fold in the cell extract
(~0.168 compared to ~0.004 U/ml). The mutation in the signal
peptide (lipAB-2) led to a slight (~4–7-fold) increase of lipase
activity in the supernatant and the cell extract, whereas the
combination of bothmutations (lipAB-3) resulted in ~100-fold
increased activity in the supernatant (~6.87 U/ml) and ~140-
fold increased activity (~0.57 U/ml) in the whole cell extract.
It should be noted here that lower lipase activities of
B. glumae PG1 wild type and B. glumae LU8093 as shown
in Fig. 2a can be attributed to the fact that these strains
harbor just one chromosomal copy of the lipAB operon.
The increased lipolytic activity of B. glumae PG1ΔlipAB
expressing plasmid-encoded lipase variants corresponded
to increased production and secretion as determined by
Western blot analysis of LipA in cell-free supernatants
(Fig. 3a, bottom). Remarkably, a significantly increased
Fig. 1 Two mutations were identified by comparative genome sequencing
and localized to the lipAB operon of the production strain B. glumae
LU8093. The first mutation is located in the lipAB promoter region (PlipAB)
and is present in the constructed variant lipAB-1; the secondmutation located
in the LipA signal peptide coding sequence is present in the constructed
variant lipAB-2; variant lipAB-3 contains both mutations. Two putative
binding sites for δ54 transcription factors and the transcription start (+1)
are underlined in the DNA sequence shown below (Beselin 2005).
Coding triplets no. 1–7 of lipA are translated into amino acid sequence,
and mutations identified in B. glumae LU8093 are marked with asterisks.
The amino acid exchange resulting from mutation lipAB-2 is indicated
Fig. 2 Lipase production of B. glumae PG1 wild type (PG1) and
production strain B. glumae LU8093. a Relative lipase activity in the
supernatant (SN) and cell extract (CE). LipA was detected in culture
supernatants (SN LipA) and LipB in cell extract (CE LipB) by Western
blotting after SDS-PAGE. Samples of 10 μl were loaded into each lane
corresponding to a cell density of O.D.580nm = 5 for cell extracts and
O.D.580nm = 50 for supernatants. b Relative change of lipA and lipB
transcript levels in B. glumae LU8093 compared to the wild type
B. glumae PG1 (arbitrarily set as 1). Error bars show standard
deviations derived from examination of three biological replicates. All
changes in transcript level are significant (see BMaterial and methods^
section)
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amount of LipB was detected only in the strains harboring
the promoter mutation (lipAB-1 and lipAB-3).
A mutation in the lipAB promoter increases the transcript
level of lipA
Next, we analyzed the influence of these mutations on the lipA
transcript level by qPCR (see Fig. 3b). Whereas the mutation
in the signal sequence (lipAB-2) exhibited just a slight effect at
the transcript level, the promoter mutation (lipAB-1 and lipAB-
3) led to an increase by a factor of 16. Interestingly, we ob-
served that the transcript levels of lipA and lipB were differ-
entially affected by the two mutations. While the lipA tran-
script level was increased by the promoter mutation, the
amount of lipB transcript remained unaffected (data not
shown). This may be explained by a faster degradation of
the lipB transcript as already suggested by Frenken et al.
(Frenken et al. 1993a). This assumption is further supported
by the observation that more LipB was detected by Western
blot analysis in strains harboring a lipase operon with the
promoter mutation than in strains with the wild type operon
(see Fig. 3a, bottom). Apparently, more lipB transcript could
be produced and translated, but may be degraded faster than
lipA transcript.
A signal peptide mutation in LipA improves secretion
in B. glumae PG1
The second mutation identified in the lipAB operon results in
an exchange of serine to leucine at position 4 of the LipA
signal peptide. This mutation has almost no effect on lipA
transcription rate, but caused a remarkable increase of extra-
cellular lipase amount (see lipAB-2 in Fig. 3). The replacement
of a polar serine by a hydrophobic leucine residue increases
the hydrophobicity of the LipA signal peptide and may thus
facilitate its interaction with the Sec-machinery thereby accel-
erating transport of LipA through the bacterial inner mem-
brane (Driessen and Nouwen 2008). This hypothesis was test-
ed by construction of alkaline phosphatase PhoA fusions to
wild type and mutant LipA signal peptides and determination
of PhoA activities in B. glumae PG1 and PG1ΔlipAB. PhoA
shows enzymatic activity only after transport across the inner
membrane and is therefore used as secretion reporter (Manoil
et al. 1990). The LipA signal peptide derived from B. glumae
LU8093 carrying mutation S4L resulted in a 2-fold increased
PhoA activity (Fig. S2).
In summary, these results indicate that the combination of
both mutations in the lipAB operon (see lipAB-3 in Fig. 3)
results in an increased transcription rate as well as in increased
lipase secretion. In addition, we did not observe any growth
defects of B. glumae PG1ΔlipAB expressing plasmid-
encoded lipAB-1 or lipAB-2 compared to the wild type lipAB
operon or the empty vector control, respectively. Expression
of lipAB-3 led to a slightly decreased cell density in the sta-
tionary growth phase after 24 h (O.D.580nm = 1.2 compared to
1.7 for wild type lipAB), which was, however, not observed
upon comparing growth of B. glumae LU8093 with the wild
type strain PG1 (data not shown).
Discussion
In this study, we analyzed the increased lipase production of
the industrial production strain B. glumae LU8093 (Fig. 2)
which is a derivate of the wild type strain B. glumae PG1.
The comparison of the genome sequences revealed 72 SNPs
Fig. 3 Expression of different lipase operons in B. glumae PG1ΔlipAB.
a Relative lipase activity in cell-free supernatants (SN) and cell extracts
(CE). LipA in supernatants (SN LipA) and LipB in cell extracts (CE
LipB) were detected by Western blotting after SDS-PAGE with each
lane containing 10 μl sample corresponding to a cell density of
O.D.580nm = 5 for cell extracts and O.D.580nm = 50 for supernatants. b
Relative change of lipA transcript levels in strains harboring a mutated
lipAB operon (lipAB-1 to −3) compared to the wild type operon lipAB
(arbitrarily set as 1). Error bars show standard deviations derived from
examination of three biological replicates. All changes in transcript level
are significant (see BMaterial and methods” section)
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introduced in the production strain by classical mutagenesis
methods with two of them being mainly responsible for in-
creased lipase production and secretion (Fig. 3). One of these
two mutations is located in the putative lipA promoter re-
gion (Fig. 1). A previous study determined the transcrip-
tional start site located 78 bases upstream of the lipA start
codon and the presence of two putative δ54-dependent pro-
moters (Beselin 2005) with the first one located at a con-
served distance of −24/−12 bp upstream of the transcrip-
tional start (Barrios et al. 1999), and the second one in a
distance of −63/−51 bp. This second putative promoter site
fits perfectly with the δ54 consensus motif GG-N8-TTGC
(Barrios et al. 1999). The promoter mutation analyzed in
this study changes this motif from −TTGC to −TTGT (see
Fig. 1). One would expect that this C-to-T transition de-
creases the lipA transcription rate, but surprisingly, it
causes an increase in lipA transcript level. The reasons
are presently unknown; however, Boekema et al. have
demonstrated that lipase expression in B. glumae PG1 but
not in LU8093 is prone to catabolite repression (Boekema
et al. 2007). The promoter mutation may thus affect bind-
ing of not only δ54 but also of other, so far unknown,
transcriptional regulators. A likely candidate could be the
cAMP receptor protein (CRP) which was shown to repress
the P. putida δ54-promoter Pu in a cAMP-dependent man-
ner (Zhang et al. 2014). In B. glumae LU8093, CRP bind-
ing affinity to the mutated promoter may be diminished
resulting in missing catabolic repression and correspond-
ingly in an overall increased transcription rate. As lipase
expression in B. glumae is also quorum sensing regulated
(Devescovi et al. 2007), the promoter SNP may addition-
ally uncouple lipase gene expression from quorum sensing
regulation. The second mutation is located in the lipA se-
quence coding for the 32 amino acid long signal peptide of
LipA and changes the polar residue serine with a hydrop-
athy value of −0.8 to a more hydrophobic leucine with a
hydropathy value of +3.8 (Kyte and Doolittle 1982) there-
by increasing lipase secretion (Fig. 3). This observation
agrees with prior studies that showed improved protein
secretion by signal peptide modifications (Yoon et al.
2010). Additive effects of additional modifications, as for
example observed for heterologous protein secretion in
Lactococcus lactis (Ng and Sarkar 2013), could further
increase LipA secretion in B. glumae. Notably, we could
demonstrate that this same mutated signal peptide also re-
sulted in a 2-fold increased secretion of PhoA (Fig. S2), a
well-established secretion reporter protein (Manoil et al.
1990). Nevertheless, it should be noted that additional 70
SNPs were identified in the production strain B. glumae
LU8093 which may also contribute to and further increase
lipase production. Interestingly, none of the SNPs is locat-
ed within or close to genes known to be involved in quo-
rum sensing or lipase secretion.
The fact that B. glumae PG1 secretes a lipase of biotech-
nological interest which is indeed used in industrial applica-
tions (Balkenhohl et al. 1997; Liese et al. 2006) raises the
question if this strain possesses additional features which
could be interesting for biotechnological applications. A very
recent study dealing with the capacity of Burkholderia to
adapt to different environments revealed certain differences
between B. glumae PG1 and other members of the plant path-
ogenic Burkholderia group (Seo et al. 2015). The most strik-
ing difference is the absence of the toxoflavin biosynthesis
and transport gene cluster in B. glumae PG1. Toxoflavin is a
phytotoxin and a major virulence factor for phytopathogenic
B. glumae strains in rice (Ham et al. 2011; Jeong et al. 2003).
B. glumae PG1 could serve as an alternative host for the pro-
duction of biotechnological relevant compounds like
rhamnolipids (Costa et al. 2011). We also identified 25 puta-
tive secondary metabolite clusters in the genome of B. glumae
PG1 (see Table S1). This further underlines the biotechnolog-
ical potential of B. glumae PG1 not only as a lipase producer,
which was demonstrated in this study, but also as a prolific
source for known and new secondary metabolites.
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